Evidence is building from epidemiological studies and laboratory investigations to support the hypothesis that abnormalities in lipoprotein metabolism during the postprandial period promote atherosclerosis. Technological advances in lipoprotein tracer studies now make it possible to study at a new level of sophistication the plasma lipoproteins that are formed postprandially in the intestine and the liver. The overall goal of the proposed research is to uncover postprandial lipoprotein pathways that are likely to influence the development of atherosclerosis, to study these pathways in normal and hypertriglyceridemic persons, and to test the effect of dietary manipulation. We will determine the fundamental metabolic pathways of the intestinal and hepatic lipoprotein particle system in plasma as traced by apolipoprotein B48 and B100; that is, what sizes of particles are produced, the extent of a lipolytic cascade, the residence times, and the existence of slowly metabolized remnant particles that are potentially atherogenic. We will study whether the presence of apolipoproteins E and C-III modulates the residence times, clearance rates and interconversions of VLDL and IDL of intestinal and hepatic origin, or whether they are markers of atherogenic remnant particles. The kinetics of apo E and C-III transfer between HDL and VLDL/IDL will be quantified.
Specific Aim 1 will compare postprandial lipoprotein kinetics during intake of a Step 1 diet with fasting lipoprotein kinetics in hypertriglyceridemic and normolipidemic subjects.
Specific Aim 2 will study the effect of substituting carbohydrate or monounsaturated fat for saturated fat on postprandial lipoprotein metabolism. Diurnal concentration patterns of lipoproteins of intestinal and hepatic origin, as well as tracer kinetics will be studied. The diurnal concentration and tracer kinetic studies are complementary, the latter delineating the mechanisms responsible for producing the peak postprandial concentrations. These studies will increase our understanding of the metabolic pathways that are activated or suppressed postprandially, and could lead to treatments for reducing the development of atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056210-02
Application #
2609366
Study Section
Nutrition Study Section (NTN)
Project Start
1997-01-01
Project End
2001-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Harvard University
Department
Nutrition
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Desai, Nirav K; Ooi, Esther M; Mitchell, Paul D et al. (2015) Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. Atherosclerosis 241:326-33
Mendivil, Carlos O; Zheng, Chunyu; Furtado, Jeremy et al. (2010) Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Arterioscler Thromb Vasc Biol 30:239-45
Zheng, Chunyu; Khoo, Christina; Furtado, Jeremy et al. (2010) Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation 121:1722-34
Zheng, Chunyu; Khoo, Christina; Furtado, Jeremy et al. (2008) Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III. Am J Clin Nutr 88:272-81
Zheng, Chunyu; Khoo, Christina; Ikewaki, Katsunori et al. (2007) Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions. J Lipid Res 48:1190-203
Campos, Hannia; Khoo, Christina; Sacks, Frank M (2005) Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis 181:345-51
Campos, H; Perlov, D; Khoo, C et al. (2001) Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res 42:1239-49
Tomiyasu, K; Walsh, B W; Ikewaki, K et al. (2001) Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol 21:1494-500